Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000601
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000654
Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000605
Concentration–Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000582
Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000572
Short communication: Pre-analytical stability of piperacillin, tazobactam, meropenem and ceftazidime in plasma and whole blood using LC-MS/MS.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000650
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000719
Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000637
Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000599
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000569
A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000604
Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000568
Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000703
Distinguishing between cyclopropylfentanyl and crotonylfentanyl by methods commonly available in the forensic laboratory.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000617
Dried blood microsampling-based therapeutic drug monitoring of anti-epileptic drugs in children with nodding syndrome and epilepsy in Uganda and the Democratic Republic of the Congo.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000720
A Compilation of Serum Concentrations of 12 Antipsychotic Drugs in a Therapeutic Drug Monitoring Setting
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000585
Ganciclovir Therapeutic Drug Monitoring: A Case Series.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000598
Impact of CYP2C19 phenotypes on clinical efficacy of stiripentol in Japanese patients with Dravet syndrome.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000676
Chinese patients with heart valve replacement do not benefit from warfarin pharmacogenetic testing on anticoagulation outcomes.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000664
A short communication: Is there a temporal relationship between trough whole blood tacrolimus concentration and acute rejection in the first 14 days after kidney transplantation?
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000656
Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000632
Therapeutic Drug Monitoring in Pregnant Patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000709
Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis.
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000631
Pharmacodynamic Monitoring of mTOR Inhibitors
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000616
Population pharmacokinetic analysis of phenytoin after intravenous administration of fosphenytoin in adult and elderly epileptic patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000651
A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000707
Development and validation of a fast U-HPLC-fluorescent method for the quantification of hydroxychloroquine and its metabolites in patients with lupus.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000614
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000699
Association of hepatic nuclear factor 4 alpha gene polymorphisms with free Imatinib plasma levels and adverse reactions in Chinese gastrointestinal stromal tumor patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000642
Increased arbekacin clearance in patients with febrile neutropenia.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000678
Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000587
A prospective investigation of the performance of two gamma-hydroxybutyric acid (GHB) tests: DrugCheck GHB Single Test and Viva-EGHB immunoassay.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000677
Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000625
Tacrolimus levels in the prophylaxis of acute graft-versus-host disease in Chinese early after hematopoietic stem cell transplantation.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000645
Quantification of the plasma concentration of apatinib by two-dimensional liquid chromatography (2D-LC).
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000609
Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate Release Tacrolimus (AAAKTRS).
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000722
A Dried Blood Spot Analysis for Solithromycin in Adolescents, Children, and Infants: A Short Communication.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000670
Short communication: Distribution of psychotropic drugs into lipoproteins.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000660
Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000698
TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000718
Improving therapeutic decisions: Pharmacodynamic monitoring as an integral part of Therapeutic Drug Monitoring.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000627
Simple and rapid quantification of the multi-enzyme targeting antifolate pemetrexed in human plasma- A short communication.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000672
Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal Function.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000690
Biomarkers of Drug-Induced Liver Toxicity.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000610
Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000571
Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000591
Population Pharmacokinetics of Vancomycin under Continuous Renal Replacement Therapy using a Polymethylmethacrylate Hemofilter.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000721
Biomarkers of Drug-Induced Kidney Toxicity.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000589
Routine Therapeutic Drug Monitoring of Dabigatran: Experience at a Tertiary Center.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000713